Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma
Alessandro Allegra, Marco Casciaro, Paola Barone, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2597-2597
Open Access | Times Cited: 14

Showing 14 citing articles:

Molecular and immunological mechanisms of clonal evolution in multiple myeloma
Stefan Förster, Ramin Radpour, Adrian F. Ochsenbein
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma
Fatemeh Karimi, Mojtaba Aghaei, Najmaldin Saki
Current Treatment Options in Oncology (2025)
Closed Access
Bone-on-a-Chip Systems for Hematological Cancers
Gül Kozalak, Ali Koşar
Biosensors (2025) Vol. 15, Iss. 3, pp. 176-176
Open Access
Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword
Sina Kamrani, Reza Naseramini, Pouria Khani, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
DNA Methylation in Ph-Negative Myeloproliferative Neoplasms: Prognostic Role and Therapeutic Implications
Paola Barone, Adele Bottaro, Rossana Leanza, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 227-227
Open Access
Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma
Alessandro Allegra, Gabriella Cancemi, Giuseppe Mirabile, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4136-4136
Open Access | Times Cited: 14
Epigenetics: Mechanisms, potential roles, and therapeutic strategies in cancer progression
Dong Wang, Yan Zhang, Qingbo Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 5, pp. 101020-101020
Open Access | Times Cited: 7
Autophagy-related mechanisms for treatment of multiple myeloma
Gül Kozalak, Ali Koşar
Cancer Drug Resistance (2023), pp. 838-57
Open Access | Times Cited: 7
Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma
Alessandro Allegra, Giuseppe Murdaca, Giuseppe Mirabile, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 514-514
Open Access | Times Cited: 2
Critical Role of Aquaporins in Cancer: Focus on Hematological Malignancies
Alessandro Allegra, Nicola Cicero, Giuseppe Mirabile, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4182-4182
Open Access | Times Cited: 6
Autoimmune Diseases and Plasma Cells Dyscrasias: Pathogenetic, Molecular and Prognostic Correlations
Laura Giordano, Rossella Cacciola, Paola Barone, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1135-1135
Open Access
m1A regulator‑mediated methylation modifications and gene signatures and their prognostic value in multiple myeloma
Jiaqi Fu, Xingjun Han, Wei Gao, et al.
Experimental and Therapeutic Medicine (2024) Vol. 29, Iss. 1
Open Access
Epigenetic Alterations in Multiple Myeloma and Potential Therapy Approaches
Gül Kozalak, Nazente Atçeken
Interdisciplinary cancer research (2024)
Closed Access
The role of High-mobility group box-1 and Psoriasin in multiple myeloma: Analysis of a population affected by monoclonal gammopathies and review of the literature
Marco Casciaro, Donatella Vincelli, Maria Ferraro, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154562-154562
Open Access | Times Cited: 1
Page 1

Scroll to top